Drupal.behaviors.print = function(context) {window.print();window.close();}>
Raising $26.9M in Public Offering, Nanosphere Anticipates Growing Dx Portfolio
July 31, 2012
Raising $26.9M in Public Offering, Nanosphere Anticipates Growing Dx Portfolio
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Following Management Changes, Nanosphere Reports Revenue Growth, but Shortfalls in Dx Placements
February 26, 2013 / BioArray News
Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News
GenMark Hopes to Expand Dx Menu This Year with Broader HCV Assay, KRAS Test, Respiratory Virus Panel
April 3, 2012 / BioArray News
Wayne State Team Developing Array for Pulmonary Sarcoidosis Diagnosis, Drug Target Discovery
February 7, 2012 / BioArray News
In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications
January 10, 2012 / BioArray News